Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial

BACKGROUND: The role of trimethylamine-N-oxide (TMAO) in type 2 diabetes (T2D) is currently partially understood and controversial. OBJECTIVE: The aim of this study was to investigate associations between TMAO and related metabolites with T2D risk in subjects at high risk of cardiovascular disease....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Clin Nutr
Päätekijät: Papandreou, Christopher, Bulló, Mònica, Zheng, Yan, Ruiz-Canela, Miguel, Yu, Edward, Guasch-Ferré, Marta, Toledo, Estefanía, Clish, Clary, Corella, Dolores, Estruch, Ramon, Ros, Emilio, Fitó, Montserrat, Arós, Fernando, Fiol, Miquel, Lapetra, José, Serra-Majem, Lluís, Gómez-Gracia, Enrique, Liang, Liming, Fragkiadakis, Georgios A, Razquin, Cristina, Hu, Frank B, Salas-Salvadó, Jordi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Original Research Communications
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6862602/
https://ncbi.nlm.nih.gov/pubmed/29982310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ajcn/nqy058
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia